Barclays »

Annovis Bio shares owned by Barclays

Quarter-by-quarter ownership of Annovis Bio (ANVS) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Annovis Bio

Tip: Access up to 7 years of quarterly data

All positions including Annovis Bio held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annovis Bio by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.5k 1.9k 1.86
2025-03-31 $0 2 0.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Annovis Bio

Empery Asset Management
Marshall Wace
Vanguard Capital Management
Tudor Investment Corporation
Renaissance Technologies
Two Sigma Investments
Susquehanna International
Citadel Advisors
Caption Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Quadrature Capital
State Street Corporation
Northern Trust

View all funds holding Annovis Bio